Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of Sitagliptin vs Glimepiride in Elderly Patients With Type 2 Diabetes Mellitus
2010-020234-26Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sitagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Merck & Co. Primary endpoint: A1C change from baseline. Started Aug 2010; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2010-020234-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020234-26.